4//SEC Filing
MAIN ALAN J 4
Accession 0001127602-23-007927
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:53 PM ET
Size
15.4 KB
Accession
0001127602-23-007927
Insider Transaction Report
Form 4
MAIN ALAN J
EVP, Pharmaceutical Research
Transactions
- Exercise/Conversion
Common Stock
2023-02-28+23,300→ 198,889 total - Exercise/Conversion
Common Stock
2023-02-28+8,976→ 207,865 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−23,300→ 0 total→ Common Stock (23,300 underlying) - Exercise/Conversion
Restricted Stock Units
2023-02-28−8,976→ 8,977 total→ Common Stock (8,976 underlying) - Exercise/Conversion
Common Stock
2023-02-28+25,667→ 233,532 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−25,667→ 51,333 total→ Common Stock (25,667 underlying) - Tax Payment
Common Stock
2023-02-28$2.17/sh−20,946$45,453→ 212,586 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001227372
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:53 PM ET
- Size
- 15.4 KB